CTN
Studies associated with:
Clinical Trials Network
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0081 | Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO) | Arjun Krishna Venkatesh, MD, MBA, MHS, Kathryn Hawk, M.D., M.H.S., Richard Andrew Taylor, MD, MHS | |
| CTN | NIDA-CTN-0079 | Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) | John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D. | |
| CTN | NIDA-CTN-0064 | Assessing Long-term CTN-0049 Outcomes, HCV Prevalence and Progression along the HCV Care Continuum among HIV/HCV Co-infected Substance Users in the U.S. | Carlos del Rio, M.D., Carmen Masson, Ph.D., Daniel J. Feaster, Ph.D., David Perlman, M.D., Lisa Metsch, Ph.D. | |
| CTN | NIDA-CTN-0095A2 | Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians | Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. | |
| CTN | NIDA-CTN-0055 | Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES) | P. Todd Korthuis, MD | |
| CTN | NIDA-CTN-0051A2 | Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051 | John Rotrosen, M.D. | |
| CTN | NIDA-CTN-0067 | Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up | P. Todd Korthuis, MD | |
| CTN | NIDA-CTN-0093 | Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool | Gerald Cochran, PhD, T. John Winhusen, Ph.D. | |
| CTN | NIDA-CTN-0075 | Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder | Li-Tzy Wu, Psy.D., Paolo Mannelli, MD | |
| CTN | NIDA-CTN-0068 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) | Madhukar H. Trivedi, M.D. | |
| CTN | NIDA-CTN-0054 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0049 | Project HOPE - Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users | Lisa Metsch, Ph.D., Carlos del Rio, M.D. | |
| CTN | NIDA-CTN-0053 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) | Kevin M. Gray, MD | |
| CTN | NIDA-CTN-0051 | Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment | John Rotrosen, M.D. | |
| CTN | NIDA-CTN-0059 | The TAPS Tool: Screen and Brief Assessment Tool Validation Study | Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D. | |
| CTN | NIDA-CTN-0056 | Testing and Linkage to HIV Care in China: A Cluster Randomized Trial | Zunyou Wu, MD, PhD | |
| CTN | NIDA-CTN-0017 | HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings | Robert Booth, Ph.D. | |
| CTN | NIDA-CTN-0047 | Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) | Michael P. Bogenschutz, M.D., Dennis Donovan, Ph.D. | |
| CTN | NIDA-CTN-0018 | Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment | Donald A. Calsyn, Ph.D. | |
| CTN | NIDA-CTN-0052 | A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) | T. John Winhusen, Ph.D. | |
| CTN | NIDA-CTN-0048 | Cocaine Use Reduction with Buprenorphine (CURB) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0046 | Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0044 | Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders | Edward V. Nunes, M.D. | |
| CTN | NIDA-CTN-0037 | Stimulant Reduction Intervention using Dosed Exercise (STRIDE) | Madhukar H. Trivedi, M.D. | |
| CTN | NIDA-CTN-AWARE | Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. – an Adaptation of CTN-0032 | Lisa Metsch, Ph.D., Grant Colfax, M.D. | |
| CTN | NIDA-CTN-0032 | HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S. | Lisa Metsch, Ph.D. | |
| CTN | NIDA-CTN-0031A | An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0031 | Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement | Dennis Donovan, Ph.D., Dennis Daley, Ph.D. | |
| CTN | NIDA-CTN-0030A3 | Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) | Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D. | |
| CTN | NIDA-CTN-0030 | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence | Walter Ling, M.D., Roger Weiss, M.D. | |
| CTN | NIDA-CTN-0029 | A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | |
| CTN | NIDA-CTN-0028 | Osmotic-Release Methylphenidate (OROS-MPH) for ADHD in Adolescents with Substance Use Disorders | Paula Riggs, M.D. | |
| CTN | NIDA-CTN-0027 | Starting Treatment with Agonist Replacement Therapies (START) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0021 | Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse | Kathleen Carroll, Ph.D., José Szapocznik, Ph.D. | |
| CTN | NIDA-CTN-0020 | Job Seekers Training for Patients with Drug Dependence | Dace Svikis, Ph.D. | |
| CTN | NIDA-CTN-0019 | Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment | Susan Tross, Ph.D. | |
| CTN | NIDA-CTN-0016 | Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment | Robert Forman, Ph.D. | |
| CTN | NIDA-CTN-0015 | Women's Treatment for Trauma and Substance Use Disorders | Denise Hien, Ph.D. | |
| CTN | NIDA-CTN-0014 | Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers | José Szapocznik, Ph.D. | |
| CTN | NIDA-CTN-0013 | Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users | T. John Winhusen, Ph.D. | |
| CTN | NIDA-CTN-0012 | Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs | Lawrence Brown, Jr., M.D., M.P.H. | |
| CTN | NIDA-CTN-0011 | A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities | Robert L. Hubbard, Ph.D., M.B.A. | |
| CTN | NIDA-CTN-0010 | Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults | George Woody, M.D. | |
| CTN | NIDA-CTN-0009 | Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs | Malcolm Reid, Ph.D. | |
| CTN | NIDA-CTN-0008 | Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation | Dennis McCarty, Ph.D. | |
| CTN | NIDA-CTN-0007 | Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics | Maxine Stitzer, Ph.D. | |
| CTN | NIDA-CTN-0006 | Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics | Maxine Stitzer, Ph.D. | |
| CTN | NIDA-CTN-0005 | MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse | Kathleen Carroll, Ph.D. | |
| CTN | NIDA-CTN-0004 | MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse | Kathleen Carroll, Ph.D. | |
| CTN | NIDA-CTN-0003 | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0002 | Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0001 | Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification | Walter Ling, M.D. |